Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder

Author： Rapkin Andrea J   McDonald Michelle   Winer Sharon A  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.3, Iss.4, 2007-07, pp. : 395-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of premenstrual dysphoric disorder

By Rapkin Andrea J   Lewis Erin I  

Women's Health, Vol. 9, Iss. 6, 2013-11 ,pp. : 537-556

Future Medicine

Access to resources Recommend Favorite

Paroxetine use in the treatment of premenstrual dysphoric disorder

By Misri Shaila   Kendrick Kristin  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 43-51

Future Medicine

Access to resources Recommend Favorite

Will oral contraceptives join SSRIs as a first-line treatment option for women with premenstrual dysphoric disorder?

By Pearlstein Teri  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 183-185

Future Medicine

Access to resources Recommend Favorite

Premenstrual Dysphoric Disorder: A Critical Review of Its Phenomenology, Etiology, Treatment and Clinical Status

By  

Current Women's Health Reviews, Vol. 14, Iss. 1, 2018-01 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness of ethinylestradiol/drospirenone for premenstrual symptoms in Japanese patients with dysmenorrhea: Open‐label pilot study

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1584-1590

John Wiley & Sons Inc

Access to resources Recommend Favorite